481 results on '"Stanciu, Carol"'
Search Results
2. Current Management and Pipeline Treatment Approaches in NAFLD: Summary of Ongoing RCTs and Future Directions
3. Obstructive Sleep Apnea Syndrome and Nonalcoholic Fatty Liver Disease
4. Nonalcoholic Fatty Liver Disease and Psoriasis
5. The Nomenclature and Definition of Nonalcoholic Fatty Liver Disease
6. Nonalcoholic Fatty Liver Disease and Chronic Kidney Disease
7. Nonalcoholic Fatty Liver Disease and Extrahepatic Malignancies
8. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis
9. Impact of Treatment with Direct Antivirals on Coagulation Parameters in Patients with Hepatitis C Virus-Related Liver Cirrhosis and Sustained Virological Response.
10. The Contribution of Genetic and Epigenetic Factors: An Emerging Concept in the Assessment and Prognosis of Inflammatory Bowel Diseases.
11. Oral Health and "Modern" Digestive Diseases: Pathophysiologic and Etiologic Factors.
12. The Rate of Burnout Syndrome in A Tertiary Gastroenterology University Center in Romania
13. Bridging the gap: Unveiling the crisis of physical inactivity in inflammatory bowel diseases
14. New Insights on Using Oral Semaglutide versus Dapagliflozin in Patients with Type 2 Diabetes and Metabolic Dysfunction-Associated Steatotic Liver Disease.
15. Clinical Implications and Management of Spontaneous Portosystemic Shunts in Liver Cirrhosis.
16. A Comprehensive Overview of the Past, Current, and Future Randomized Controlled Trials in Hepatic Encephalopathy
17. The Impact of Alcohol Consumption Pattern on Liver Fibrosis in Asymptomatic Patients
18. Small Bowel Capsule Endoscopy and Enteroscopy: A Shoulder-to-Shoulder Race
19. Reclassification of Inflammatory Bowel Disease Type Unclassified by Small Bowel Capsule Endoscopy
20. Duodenoscope-associated infections: a review
21. Real-World Utilization of Corticosteroids in Severe Alcoholic Hepatitis: Eligibility, Response, and Outcomes.
22. Coagulation Dysfunctions in Non-Alcoholic Fatty Liver Disease—Oxidative Stress and Inflammation Relevance
23. Gastrointestinal Manifestations of IgA Vasculitis-Henoch-Schönlein Purpura
24. The Relation between Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis and Different Cannulation Techniques: The Experience of a High-Volume Center from North-Eastern Romania
25. Nonalcoholic steatohepatitis: A scientometric analysis of publications during 1980–2018
26. Impaired Intestinal Permeability Assessed by Confocal Laser Endomicroscopy—A New Potential Therapeutic Target in Inflammatory Bowel Disease
27. Anticoagulation for Atrial Fibrillation in Patients with Decompensated Liver Cirrhosis: Bold and Brave?
28. Changes in Components of Metabolic Syndrome after Antiviral Eradication in Hepatitis C Virus Infection
29. Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: The IMPORTAL competing-risk meta-analysis
30. Improvement of carotid atherosclerosis and peripheral artery disease after hepatitis C virus eradication by direct-acting antivirals.
31. High prevalence of liver fibrosis among general population: a Romanian population-based study
32. Real World Efficacy and Safety of Sofosbuvir + Velpatasvir + Voxilaprevir in Romanian Patients with Genotype 1b HCV Infection Non-reponders to DAAs Therapy
33. Predictive Factors for the Prognosis of Alcoholic Liver Cirrhosis
34. Assessing the Neurotoxicity of a Sub-Optimal Dose of Rotenone in Zebrafish (Danio rerio) and the Possible Neuroactive Potential of Valproic Acid, Combination of Levodopa and Carbidopa, and Lactic Acid Bacteria Strains
35. Screening for Liver Steatosis and Fibrosis in Patients with Inflammatory Bowel Disease Using Vibration Controlled Transient Elastography with Controlled Attenuation Parameter
36. The Role of Presepsin and Procalcitonin in Early Diagnosis of Bacterial Infections in Cirrhotic Patients with Acute-on-Chronic Liver Failure
37. The Role of Presepsin in Diagnosing Infections in Patients with Liver Cirrhosis and Overt Hepatic Encephalopathy
38. Clostridium difficile infection in hospitalized octogenarian patients
39. Portal Vein Thrombosis in Patients with Liver Cirrhosis
40. Efficacy and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with ribavirin for the treatment of HCV genotype 1b compensated cirrhosis in patients aged 70 years or older
41. Simultaneously Screening for Liver Steatosis and Fibrosis in Romanian Type 2 Diabetes Mellitus Patients Using Vibration-Controlled Transient Elastography with Controlled Attenuation Parameter
42. Ischemic Heart Disease and Liver Cirrhosis: Adding Insult to Injury
43. Improved recurrence-free survival rates in patients with HCV-related hepatocellular carcinoma and sustained virological response to direct-acting antivirals
44. Idiopathic Cervical Esophageal Webs: A Case Report and Literature Review
45. β-Blockers in Decompensated Cirrhosis: More Questions Than Answers
46. A study of the levels of glutathione peroxidase in patients with spontaneous bacterial peritonitis
47. Performances of Elasto-FibroTest®, a combination between FibroTest® and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C
48. Clinical and Laboratory Characteristics of Normal Weight and Obese Individuals with Non-Alcoholic Fatty Liver Disease
49. Romanian Guidelines for the Diagnosis and Treatment of GERD-induced Respiratory Manifestations
50. Changes in Liver Steatosis Using Controlled Attenuation Parameter among Patients with Chronic Hepatitis C Infection Treated with Direct-Acting Antivirals Therapy Who Achieved Sustained Virological Response
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.